GSA CAPITAL PARTNERS LLP - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 89 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,754
+65.8%
406,019
+152.9%
0.15%
+41.5%
Q2 2023$1,058
+78.4%
160,524
+83.8%
0.11%
+79.7%
Q1 2023$593
-36.0%
87,337
-30.3%
0.06%
-48.7%
Q4 2022$926
-99.8%
125,366
+141.7%
0.12%
+69.1%
Q3 2022$512,000
+59.0%
51,866
+82.1%
0.07%
+58.1%
Q1 2022$322,000
+13.4%
28,482
+57.4%
0.04%
+19.4%
Q4 2021$284,000
-21.8%
18,092
-18.3%
0.04%
-14.3%
Q4 2019$363,000
-48.0%
22,135
-57.9%
0.04%
-55.3%
Q3 2019$698,000
+123.7%
52,594
+340.3%
0.09%
+161.1%
Q4 2018$312,000
-16.1%
11,945
-26.3%
0.04%
+71.4%
Q3 2018$372,000
+60.3%
16,198
+11.4%
0.02%
+50.0%
Q4 2016$232,000
-21.6%
14,535
-18.4%
0.01%
-12.5%
Q3 2016$296,000
+13.4%
17,804
-42.9%
0.02%
-5.9%
Q1 2016$261,000
+17.6%
31,180
+30.8%
0.02%
+54.5%
Q4 2015$222,000
-62.6%
23,839
-54.7%
0.01%
-62.1%
Q3 2015$594,000
+147.5%
52,670
+255.2%
0.03%
+163.6%
Q2 2014$240,000
-46.3%
14,828
-46.2%
0.01%
-65.6%
Q1 2014$447,000
+299.1%
27,538
+169.7%
0.03%
+255.6%
Q3 2013$112,00010,2120.01%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,715,000$19,345,0007.65%
Avoro Capital Advisors LLC 2,124,593$23,965,0006.23%
Asymmetry Capital Management, L.P. 118,707$1,339,0002.98%
ARMISTICE CAPITAL, LLC 760,000$8,573,0002.93%
Consonance Capital Management LP 1,436,796$16,207,0002.28%
Palo Alto Investors LP 3,997,108$45,087,0002.17%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,784,157$53,965,0002.09%
PURA VIDA INVESTMENTS, LLC 247,500$2,792,0001.59%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,943,267$21,920,0001.06%
SPHERA FUNDS MANAGEMENT LTD. 513,390$5,791,0000.74%
View complete list of VANDA PHARMACEUTICALS INC shareholders